- Previous Close
26.00 - Open
26.00 - Bid 25.80 x 60000
- Ask 26.20 x 60000
- Day's Range
26.00 - 26.00 - 52 Week Range
22.80 - 26.80 - Volume
507 - Avg. Volume
59 - Market Cap (intraday)
47.32M - Beta (5Y Monthly) -0.10
- PE Ratio (TTM)
∞ - EPS (TTM)
0.00 - Earnings Date May 27, 2025
- Forward Dividend & Yield 0.95 (3.65%)
- Ex-Dividend Date Mar 26, 2025
- 1y Target Est
--
MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, it develops and sells software licenses; and provides services for technical visualization and online training. The company was incorporated in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.
www.mevis.de100
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: M3V.DE
View MorePerformance Overview: M3V.DE
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: M3V.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: M3V.DE
View MoreValuation Measures
Market Cap
47.32M
Enterprise Value
40.79M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.79
Price/Book (mrq)
2.65
Enterprise Value/Revenue
2.40
Enterprise Value/EBITDA
8.43
Financial Highlights
Profitability and Income Statement
Profit Margin
26.87%
Return on Assets (ttm)
9.13%
Return on Equity (ttm)
25.58%
Revenue (ttm)
16.97M
Net Income Avi to Common (ttm)
4.56M
Diluted EPS (ttm)
0.00
Balance Sheet and Cash Flow
Total Cash (mrq)
6.53M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.43M